WallStreetZenWallStreetZen

NASDAQ: FBRX
Forte Biosciences Inc Stock Ownership - Who owns Forte Biosciences?

Insider buying vs selling

Have Forte Biosciences Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Paul A. WagnerCEO President Secretary and Chair of the Board2022-12-1644,024$1.07
$47.02kBuy
Paul A. WagnerCEO President Secretary and Chair of the Board2022-12-1555,976$1.03
$57.66kBuy

1 of 1

FBRX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when FBRX insiders and whales buy or sell their stock.

FBRX Shareholders

What type of owners hold Forte Biosciences Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Steven Michael Oliveira19.71%4,139,450$4.14MInsider
Paul A. Wagner6.57%1,379,049$1.38MInsider
Vanguard Group Inc3.08%647,293$647.29kInstitution
Newtyn Management LLC2.38%500,000$500.00kInstitution
Renaissance Technologies LLC2.11%444,129$444.13kInstitution
Harry E. Gruber2.10%441,438$441.44kInsider
Douglas Jolly2.08%436,956$436.96kInsider
Dennis N. Berman1.17%246,376$246.38kInsider
Faheem Hasnain1.17%245,857$245.86kInsider
Blackrock Inc1.01%212,061$212.06kInstitution

1 of 3

FBRX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
FBRX12.72%33.48%Net BuyingNet Buying
MTCR10.92%89.08%Net BuyingNet Selling
ACGN3.78%96.22%Net BuyingNet Selling
CRBP18.65%7.93%Net Buying
ANGN16.99%24.83%Net Buying

Forte Biosciences Stock Ownership FAQ

Who owns Forte Biosciences?

Forte Biosciences (NASDAQ: FBRX) is owned by 12.72% institutional shareholders, 33.48% Forte Biosciences insiders, and 53.80% retail investors. Steven Michael Oliveira is the largest individual Forte Biosciences shareholder, owning 4.14M shares representing 19.71% of the company. Steven Michael Oliveira's Forte Biosciences shares are currently valued at $4.22M.

If you're new to stock investing, here's how to buy Forte Biosciences stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.